U.S.
LocationRelationship Network
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Merkel
|
Unknown |
9
Strong
|
1 |
HOUSE_OVERSIGHT_024891.jpg
This document is a market research report from Cowen Washington Research Group dated February 25, 2019, authored by Assaraf and watermarked for Michael Cella. It analyzes the regulatory landscape for CBD following the passage of the 2018 Farm Bill, specifically highlighting that while hemp was declassified, the FDA (under Commissioner Scott Gottlieb) retains authority over CBD products making health claims or used in food. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a Congressional investigation.
HOUSE_OVERSIGHT_024878.jpg
This document is page 62 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing the CBD market. It provides detailed profiles of four companies: Mary's Whole Pet/Nutritionals, Mile High Labs, Papa & Barkley, Recess, and Reliva CBD Wellness, discussing their products, funding, and strategies. The document bears a 'HOUSE_OVERSIGHT' footer, indicating it was part of materials reviewed by the House Oversight Committee.
HOUSE_OVERSIGHT_024877.jpg
This document is page 61 of a 'Cowen Collaborative Insights' report dated February 25, 2019, analyzing private companies in the CBD/hemp industry (Botanica, GenCanna, Highline Wellness, Lazarus Naturals, Lord Jones, and Mary's). While stamped 'HOUSE_OVERSIGHT_024877', indicating it is part of a larger document production (likely related to financial oversight), the page content itself is purely market research and contains no direct references to Jeffrey Epstein or his associates. The sidebar indicates the report was intended for Michael Cella at Cowen.
HOUSE_OVERSIGHT_024872.jpg
This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024851.jpg
This document is page 35 of a financial research report produced by Cowen on February 25, 2019, analyzing the U.S. CBD market, specifically focusing on 'Topicals.' The report projects the topical CBD market to grow to $1.5 billion by 2020. The document bears a 'HOUSE_OVERSIGHT_024851' Bates stamp, indicating it was obtained during a House Oversight Committee investigation, though the content of this specific page is purely financial market analysis and does not explicitly mention Jeffrey Epstein.
HOUSE_OVERSIGHT_024843.jpg
This document is page 27 of a Cowen Collaborative Insights financial report dated February 25, 2019. The content is a market analysis of the CBD (Cannabidiol) industry, breaking down price per milligram across various product categories such as tinctures, gummies, and beauty products. While the content itself is strictly financial research regarding consumer staples, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024843', indicating it was part of a document production for a US House Oversight Committee investigation.
HOUSE_OVERSIGHT_024837.jpg
This document is page 21 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing a strategic partnership between Cronos Group and Ginkgo Bioworks valued at $122MM. The text details the financial structure of the deal, including R&D funding and equity milestones for producing specific cannabinoids like THC and CBD. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, likely included in a larger cache of internal financial documents.
HOUSE_OVERSIGHT_024836.jpg
This document is page 20 of a Cowen 'Collaborative Insights' financial research report dated February 25, 2019. It details the scientific process of biosynthetic cannabinoid production via fermentation and highlights a specific February 2019 business deal where Amyris signed a partnership valued at up to $255 million with an 'undisclosed partner.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the U.S. House Oversight Committee.
HOUSE_OVERSIGHT_024823.jpg
This document is page 7 of a financial research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. It outlines the anticipated growth of the U.S. CBD market to $16 billion by 2025 and lists various analysts covering specific sectors such as consumer products, pharmacy, and regulation. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was likely produced as part of a congressional investigation, possibly related to banking records, though the text itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024821.jpg
This Cowen report page discusses the global regulatory landscape for CBD, highlighting developments in Europe and Latin America, and analyzes the U.S. regulatory outlook following the 2018 Farm Bill. It details the shifting oversight from the DEA to the Department of Agriculture while noting continued FDA authority and regulatory uncertainty regarding CBD products.
HOUSE_OVERSIGHT_024819.jpg
A Cowen equity research report titled 'Cowen's Collective View of CBD - Ahead of the Curve Series,' dated February 25, 2019. The document analyzes the U.S. CBD market, projecting a $16 billion opportunity by 2025, and discusses consumer trends, scientific understanding, and hemp cultivation. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024819) and a watermark indicating it was intended for Michael Cella at Cowen.
HOUSE_OVERSIGHT_024773.jpg
This document serves as the introduction to Chapter VIII of an Ackrell Capital report, presenting their 2018 list of the top 100 private cannabis companies. The text outlines the subjective selection criteria, highlights the financial risks and challenges faced by early-stage cannabis companies, and includes a disclaimer regarding potential conflicts of interest due to Ackrell Capital's investment activities.
HOUSE_OVERSIGHT_024751.jpg
This document from Ackrell Capital provides a sensitivity analysis for the international legal cannabis market size, forecasting a potential global market exceeding $300 billion within 10-15 years. It includes estimates excluding major Asian markets but notes the potential for the market to exceed $500 billion if countries like China and Japan legalize cannabis. The page concludes with a disclaimer regarding the uncertainty of these predictions and potential risks to the industry.
HOUSE_OVERSIGHT_024747.jpg
This document is a page from a 2017 market research report by Ackrell Capital regarding U.S. legalized cannabis market estimates. It includes a bar chart projecting market growth and consumer numbers from 2016 to 2030, contingent on federal legalization milestones. It also provides a sensitivity analysis table showing estimated 2030 market size based on varying population penetration rates and monthly consumer spending. The document bears a House Oversight stamp, suggesting it was part of a larger document production.
HOUSE_OVERSIGHT_024737.jpg
This page from an Ackrell Capital report discusses the global outlook for cannabis regulation, identifying 2018 as a critical year due to recreational legalization efforts in Canada and California. It argues that the future stance of the U.S. federal government regarding enforcement or legalization will be the single most impactful factor on the global industry's trajectory.
HOUSE_OVERSIGHT_024076.jpg
This document appears to be page 65 of a confidential offering memorandum or similar financial disclosure document for an investment fund. It details specific risk factors and strategies, including leverage risks, investments in public companies, hedging techniques (specifically 'selling short against the box'), portfolio trading policies, and risks associated with non-U.S. investments. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it is part of a congressional investigation.
HOUSE_OVERSIGHT_024072.jpg
This document appears to be page 61 of a confidential private placement memorandum or risk disclosure statement for a biopharmaceutical investment fund. It outlines risks related to healthcare legislation (Medicare/Medicaid), the availability of investment capital for portfolio companies, and general economic market risks. The document bears a House Oversight Committee Bates stamp, suggesting it was obtained during a congressional investigation, likely related to financial entities connected to Jeffrey Epstein.
HOUSE_OVERSIGHT_029953.jpg
This document appears to be page 22 of a geopolitical analysis or article written by maritime policy analyst Mark Valencia. It discusses tensions in the South China Sea, specifically focusing on the disconnect between China's civilian leadership and the PLA Navy, evidenced by a stealth fighter test conducted during U.S. Secretary of Defense Robert Gates' visit. The text warns of worsening situations involving Vietnam, drilling rights, and protests in Hanoi and Manila. The document bears a House Oversight stamp, suggesting it was part of a production of documents, likely related to an investigation involving communications or briefing materials.
HOUSE_OVERSIGHT_029952.jpg
This document page (marked page 21 and Bates stamped HOUSE_OVERSIGHT_029952) contains a geopolitical analysis of tensions between China and the U.S. regarding the South China Sea. It discusses China's 'nine-dashed line' claim, the Law of the Sea Treaty (which the U.S. has not ratified), and suggests that aggressive U.S. containment strategies may be leading Chinese leadership to believe war is inevitable. The text appears to be part of a larger report or academic paper analyzing international law and military strategy.
HOUSE_OVERSIGHT_029848.jpg
An email from Richard Kahn to Jeffrey Epstein (using the alias Jeffrey E. / jeevacation@gmail.com) dated January 26, 2017. Kahn shares news snippets and tweets regarding President Trump's diplomatic dispute with Mexico over the border wall and trade deficits. Kahn explicitly praises Trump, stating, 'love his negotiating style as he makes me look soft..'
HOUSE_OVERSIGHT_029824.jpg
This document appears to be a page from a policy paper or essay discussing U.S. international economic strategy. It reviews the historical success of Reagan's economic policies in the 1980s and proposes a new strategy involving strengthening NAFTA ties with Canada and Mexico. It also discusses the risks associated with the Federal Reserve's continued near-zero interest rate policies.
HOUSE_OVERSIGHT_029770.jpg
This document details various aspects of Jeffrey Epstein's legal troubles and social connections, including allegations of molestation and sex trafficking, the leniency of his previous sentence, and the ongoing Justice Department investigation. It highlights his use of private jets for alleged illicit trips and lists prominent individuals who were reportedly passengers on his aircraft, questioning whether his wealth and connections helped him evade justice. The document also mentions his completion of a house arrest sentence and recent settlements with victims.
HOUSE_OVERSIGHT_029738.jpg
This document page, marked with a House Oversight Bates stamp, appears to be an excerpt from a policy paper or testimony regarding international economics. The text discusses the risks of competitive devaluation and currency manipulation (referencing China), the need to withdraw from 'cheap money' policies, and the roles of the IMF and WTO in regulating exchange rates. The author, likely affiliated with the Peterson Institute, advocates for the U.S. to strengthen trade through the WTO and finalize aspects of the Doha Round negotiations.
HOUSE_OVERSIGHT_029625.jpg
Jeffrey Epstein forwards an email to Lesley Groff containing the text of an article by Conchita Sarnoff published in August 2010. The article details Epstein's lenient sentence, allegations of sex trafficking underage girls, political interference by the Justice Department, and settlements paid to victims. It highlights specific details regarding international trafficking, police intimidation, and asset movement.
HOUSE_OVERSIGHT_029527.jpg
This document is a printout of a 'The Real Deal' article dated June 26, 2019, detailing fraud allegations against Walsh and SARC regarding the Palm House EB-5 project. The text outlines how Walsh allegedly misled investors with false claims about financing, including non-existent bank loans and developer equity, while promising lavish rewards like jet and yacht access. Walsh is reported to have fled the U.S., possibly to Vietnam or Australia, to avoid facing charges.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity